Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Schneyer Mark C. sold 3,506 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded May 1 to May 4, 2026 · Filed May 5, 2026

From May 1 to May 4, 2026, Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold 3,506 Acadia Pharmaceuticals Inc. shares at US$21.79 for US$76,396, leaving 66,145 shares. Filed May 5, 2026 (Form 4).

Sold
3,506 shares
Price
US$21.79
Value
US$76,396
Holding after
66,145 shares
Trading plan
No
Role
EVP, CHIEF FINANCIAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 1, 2026Common StockOption exercise6,81569,651Direct
May 4, 2026Common StockSale3,506US$21.7966,145Direct

Source

View original at SEC

Related